Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Hashimoto

Showing results (181-190 of 271) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry|March 25, 2015
Structure-activity relationships of benzhydrol derivatives based on 1'-acetoxychavicol acetate (ACA) and their inhibitory activities on multiple myeloma cell growth via inactivation of the NF-κB pathwayTakashi Misawa, Kosuke Dodo, Minoru Ishikawa, et al.
Chemical Communications (Cambridge, England)|August 6, 2025
Phthalimide: a potential warhead for switchable and bioorthogonal conjugationKosuke Chiba, Takumi Yoshida, Kana Okada, et al.
Journal of Neurochemistry|March 22, 2002
Neurotoxic mechanisms triggered by Alzheimer's disease-linked mutant M146L presenilin 1: involvement of NO synthase via a novel pertussis toxin targetYuichi Hashimoto, Yuko Ito, Erika Arakawa, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone SkeletonYuko Nishiyama, Shuichi Mori, Makoto Makishima, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) delta selective antagonistsJun-ichi Kasuga, Seiichi Ishida, Daisuke Yamasaki, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 proteinHiromitsu Fukuda, Fumika Karaki, Kosuke Dodo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2020
A key mammalian cholesterol synthesis enzyme, squalene monooxygenase, is allosterically stabilized by its substrateHiromasa Yoshioka, Hudson W Coates, Ngee Kiat Chua, et al.
International Journal of Molecular Medicine|January 22, 2008
Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomideToyotaka Iguchi, Tomomi Yachide-Noguchi, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
Improvement of the transactivation activity of phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists: effect of introduction of fluorine at the linker partJun-ichi Kasuga, Takuji Oyama, Yuko Hirakawa, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 25, 2017
1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulatorsKaori Endo-Umeda, Atsushi Aoyama, Masato Shimizu, et al.
Pageof 28

Showing results (181-190 of 271) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry|March 25, 2015
Structure-activity relationships of benzhydrol derivatives based on 1'-acetoxychavicol acetate (ACA) and their inhibitory activities on multiple myeloma cell growth via inactivation of the NF-κB pathwayTakashi Misawa, Kosuke Dodo, Minoru Ishikawa, et al.
Chemical Communications (Cambridge, England)|August 6, 2025
Phthalimide: a potential warhead for switchable and bioorthogonal conjugationKosuke Chiba, Takumi Yoshida, Kana Okada, et al.
Journal of Neurochemistry|March 22, 2002
Neurotoxic mechanisms triggered by Alzheimer's disease-linked mutant M146L presenilin 1: involvement of NO synthase via a novel pertussis toxin targetYuichi Hashimoto, Yuko Ito, Erika Arakawa, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone SkeletonYuko Nishiyama, Shuichi Mori, Makoto Makishima, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) delta selective antagonistsJun-ichi Kasuga, Seiichi Ishida, Daisuke Yamasaki, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 proteinHiromitsu Fukuda, Fumika Karaki, Kosuke Dodo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2020
A key mammalian cholesterol synthesis enzyme, squalene monooxygenase, is allosterically stabilized by its substrateHiromasa Yoshioka, Hudson W Coates, Ngee Kiat Chua, et al.
International Journal of Molecular Medicine|January 22, 2008
Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomideToyotaka Iguchi, Tomomi Yachide-Noguchi, Yuichi Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
Improvement of the transactivation activity of phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists: effect of introduction of fluorine at the linker partJun-ichi Kasuga, Takuji Oyama, Yuko Hirakawa, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 25, 2017
1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulatorsKaori Endo-Umeda, Atsushi Aoyama, Masato Shimizu, et al.
Pageof 28